Reported Apr 29, 2015 · Terminated

Mucinex DM (guaifenesin 600mg and dextromethorphan HBr 30mg), extended-release bi-layer tablets, 2 tablets per pouch…

Reckitt Benckiser LLC

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Reckitt Benckiser LLC · 399 Interpace Pkwy · Parsippany, NJ · 07054-1133

Is this the product you have?

  • Mucinex DM (guaifenesin 600mg and dextromethorphan HBr 30mg), extended-release bi-layer tablets, 2 tablets per pouch (NDC 63824-056-72), OTC, Distributed by Reckitt Benckiser, Parsippany, NJ 07054-0224 Made in England
Lot codes and dates
    • Lot BD375 exp 06/2016
    • BD566
    • BD661 exp. 08/2016
Amount recalled
155 cases (2000 pouches of 2 tablets per case)

Where it was sold

  • Nationwide

Why it was recalled

Defective container: A customer complaint revealed the presence of a defective seal on the top of a Mucinex pouch

This product is unlikely to cause harm, but it breaks a safety or labelling rule.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Reckitt Benckiser LLC recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Mar 30, 2018 · Data as of Sep 19, 7:20 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.